(Q80243420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Human visceral adipose tissue and the plasminogen activator inhibitor type 1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Lindeman JH

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Toet K

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Eilers PH

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

van Ramshorst B

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Buijs MM

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

van Bockel JH

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Kooistra T

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1671-1679

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17471294%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803650

30 December 2019

exact match

0 references

cites work

PAI-1 and the metabolic syndrome: links, causes, and consequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Plasminogen-activator inhibitor type 1 and coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Adipose tissue as a source of inflammatory cytokines in health and disease: Focus on end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Leptin and the proinflammatory state associated with human obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Acipimox enhances spontaneous growth hormone secretion in obese women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Adipokines: molecular links between obesity and atheroslcerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Growth hormone blunts protein oxidation and promotes protein turnover to a similar extent in abdominally obese and normal-weight women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Insulin resistance in type 2 diabetes: role of fatty acids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Dyslipidemia in visceral obesity: mechanisms, implications, and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Postprandial triglycerides and blood coagulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Dyslipidaemia, hypercoagulability and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Visceral adipose tissue and low-density lipoprotein particle size in middle-aged versus young men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Visceral fat and insulin resistance--causative or correlative?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021

Insulin resistance and clinical aspects of non-alcoholic steatohepatitis (NASH).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803650

7 January 2021